Xybion Digital to Participate in the Maxim Group LLC and M-Vest Hosted Healthcare IT Virtual Conference

VANCOUVER, BC and PRINCETON, NJ / ACCESSWIRE / January 18, 2024 / Xybion Digital Inc. (TSXV:XYBN) ("Xybion" or the "Company"), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences, announced today that Company Chairman and CEO, Dr. Pradip Banerjee has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest on Thursday, January 25, 2024, at 10:30 AM ET. The conference is scheduled as a two-day event and will be held virtually on January 24-25, 2024, starting at 9:00 AM ET.

Allen Klee, Senior Research Analyst at Maxim Group, will engage with representatives from various Healthcare and IT companies, including Xybion Digital, to discuss innovative strategies for reducing healthcare costs, benefiting healthcare providers, and elevating the customer experience.

The event will feature presentations for leveraging the latest technology and AI with a focus on improving healthcare outcomes and a transition to value-based care models. Additionally, the conference will spotlight organizations striving to provide cost-effective, remote solutions and timely monitoring of patient risk factors.

This conference will be live on M-Vest. To attend, sign up to become an M-Vest member. 

Click Here to Reserve Your Seat.

About Xybion Digital Inc.

For further information: For more information regarding Xybion Digital Inc., please contact Pradip Banerjee, Chief Executive Officer, PBanerjee@xybion.com, 609-512-5790 x122

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements ("forward-looking statements") in this news release may contain forward-looking information concerning relating to the release of financial results, plans related to the Company's business and other matters that may occur in the future, made as of the date of this news release. In making the forward-looking statements included in this news release, the Company has applied several material assumptions, including with respect to the timing of such release. Although management considers these assumptions to be reasonable based on information available to it, they may prove to be incorrect.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements as a number of important factors could cause the actual outcomes to differ materially from the expectations expressed in them. Such factors include, among others, the risks described in disclosure documents filed by the Company on SEDAR. There can be no assurance that forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by applicable securities legislation.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

CONTACT:

hjurolan@xybion.com

SOURCE: Xybion Digital Inc.